Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-04-24

Clinical Trial Update: Pomegranate to Reduce Maternal and Fetal Oxidative Stress and Improve Outcome in Pregnancies Complicated With Preterm Premature Rupture of the Membranes [NA]

View source ↗

Summary

A clinical trial is evaluating whether pomegranate can reduce maternal and fetal oxidative stress and improve outcomes in pregnancies affected by preterm premat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pomegranate (Punica granatum extract)

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Preterm Premature Rupture of Membranes, Pregnant State | NA | Status: UNKNOWN